Golimumab
- Biologic
- SIMPONI ARIA
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Golimumab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Refrigerate SIMPONI ARIA at 36 ⁰F to 46 ⁰F (2 ⁰C to 8 ⁰C) and protect from light.
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- up to 30 days
Label statement
If needed, SIMPONI ARIA may be stored at room temperature up to 77 ºF (25 ºC) for a maximum single period of 30 days in the original carton to protect from light.
- Room temperature
- up to 30 days
Label statement
If not used within 30 days at room temperature, discard SIMPONI ARIA.
- Back into the refrigerator
- Not allowed
Label statement
Once SIMPONI ARIA has been stored at room temperature, do not return the product to the refrigerator.
- Light
- Protect from light
Label statement
Refrigerate SIMPONI ARIA at 36 ⁰F to 46 ⁰F (2 ⁰C to 8 ⁰C) and protect from light.
- Shaking
- Do not shake
Label statement
Do not shake.
All storage statements on the label (7)
- Refrigerate SIMPONI ARIA at 36 ⁰F to 46 ⁰F (2 ⁰C to 8 ⁰C) and protect from light.
- Keep the product in the original carton to protect from light until the time of use.
- Do not freeze.
- Do not shake.
- If needed, SIMPONI ARIA may be stored at room temperature up to 77 ºF (25 ºC) for a maximum single period of 30 days in the original carton to protect from light.
- Once SIMPONI ARIA has been stored at room temperature, do not return the product to the refrigerator.
- If not used within 30 days at room temperature, discard SIMPONI ARIA.
FDA label version 28, effective September 9, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Biosimilars
Simponi: 2 licensed biosimilar products, 2 interchangeable (FDA Purple Book). Compare presentations and dates
Medicare Part D coverage
No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.